UnitedHealth (UNH) is a publicly traded Healthcare sector company. As of November 15, 2026, UNH trades at $407.46 with a market cap of $365.09B and a P/E ratio of 24.09. UNH moved +0.54% today. Year to date, UNH is +19.13%; over the trailing twelve months it is +22.54%. Its 52-week range spans $234.60 to $606.36. Analyst consensus is strong buy with an average price target of $482.69. Rallies surfaces UNH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for UNH, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $407.46 |
| Market Cap | $365.09B |
| P/E Ratio | 24.09 |
| EPS | $15.58 |
| Dividend Yield | 2.32% |
| 52-Week High | $606.36 |
| 52-Week Low | $234.60 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $450.13B |
| Net Income | $14.91B |
| Gross Margin | 88.57% |
17 analysts cover UNH: 0 strong buy, 14 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $482.69.